comparemela.com

Latest Breaking News On - Director jacqueline - Page 1 : comparemela.com

Q1 2025 EPS Estimates for STERIS plc Reduced by Analyst (NYSE:STE)

STERIS plc (NYSE:STE – Free Report) – Equities research analysts at Zacks Research decreased their Q1 2025 EPS estimates for STERIS in a research report issued on Wednesday, May 29th. Zacks Research analyst R. Department now expects that the medical equipment provider will earn $2.07 per share for the quarter, down from their prior estimate […]

Westfield Capital Management Co LP Invests $60 66 Million in MKS Instruments, Inc (NASDAQ:MKSI)

Westfield Capital Management Co. LP bought a new position in shares of MKS Instruments, Inc. (NASDAQ:MKSI – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 589,715 shares of the scientific and technical instruments company’s stock, valued at approximately $60,664,000. Westfield Capital Management […]

KeyCorp Raises MKS Instruments (NASDAQ:MKSI) Price Target to $150 00

MKS Instruments (NASDAQ:MKSI – Free Report) had its target price lifted by KeyCorp from $140.00 to $150.00 in a report released on Thursday morning, Benzinga reports. They currently have an overweight rating on the scientific and technical instruments company’s stock. Several other research analysts have also recently weighed in on MKSI. Needham & Company LLC […]

Coldstream Capital Management Inc Buys 1,338 Shares of STERIS plc (NYSE:STE)

Coldstream Capital Management Inc. increased its stake in shares of STERIS plc (NYSE:STE – Free Report) by 13.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 11,224 shares of the medical equipment provider’s stock after purchasing an additional 1,338 shares during the quarter. Coldstream Capital Management Inc.’s holdings in STERIS were worth $2,467,000 at […]

STERIS plc (NYSE:STE) Receives $241 60 Consensus Price Target from Brokerages

STERIS plc (NYSE:STE – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six analysts that are currently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year price […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.